Embosphere® PROstate Post Market Study
Public ClinicalTrials.gov record NCT03527589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Post Market Study of Patients With Symptomatic Benign Prostatic Hyperplasia Treated by Prostatic Artery Embolization With Embosphere® Microspheres
Study identification
- NCT ID
- NCT03527589
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Merit Medical Systems, Inc.
- Industry
- Enrollment
- 499 participants
Conditions and interventions
Interventions
- Prostate artery embolization Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 15, 2018
- Primary completion
- Jan 20, 2020
- Completion
- Jan 21, 2022
- Last update posted
- Dec 17, 2023
2018 – 2022
United States locations
- U.S. sites
- 8
- U.S. states
- 4
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VA Long Beach Healthcare Systems | Long Beach | California | 90822 | — |
| Ronald Reagan UCLA Medical Center | Los Angeles | California | 90095 | — |
| University of California Los Angeles | Los Angeles | California | 90095 | — |
| UC Irvine Health | Orange | California | 92868 | — |
| Holy Cross Hospital | Fort Lauderdale | Florida | 33308 | — |
| University of Miami- Miller School of Medicine | Miami | Florida | 33136 | — |
| St. Louis University Hospital | St Louis | Missouri | 63110 | — |
| Providence Sacred Heart | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03527589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2023 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03527589 live on ClinicalTrials.gov.